Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
April 8, 2009Clinical Cancer ResearchOpen Access

Noninvasive Detection of EGFR T790M in Gefitinib or Erlotinib Resistant Non–Small Cell Lung Cancer

View Full Paper
Ask AI
Bookmark
Share

Authors

YKYanan KuangDana-Farber Cancer InstituteARAndrew M. RogersTufts UniversityBYBeow Y. YeapMassachusetts General Hospital

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Kuang et al. (2009) studied this question.

synapsesocial.com/papers/6a0cde460f2e12c3ee1f56a8https://doi.org/10.1158/1078-0432.ccr-08-2592
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Multicentre prospective phase II trial of gefitinib for advanced non-small cell lung cancer with epidermal growth factor receptor mutations: results of the West Japan Thoracic Oncology Group trial (WJTOG0403)2008 · 204 citations
  2. 2Gefitinib for non-small-cell lung cancer patients with epidermal growth factor receptor gene mutations screened by peptide nucleic acid-locked nucleic acid PCR clamp2006 · 168 citations
  3. 3Comparison of Four Chemotherapy Regimens for Advanced Non–Small-Cell Lung Cancer2002 · 5,010 citations
  4. 4Micronutrient Sprinkles to Control Childhood Anaemia2005 · 227 citations
  5. 5Detection of Mutations in EGFR in Circulating Lung-Cancer Cells2008 · 1,618 citations